| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 05/13/2003 | US6562962 Preparation of substituted isoserine esters using metal alkoxides and β-lactams |
| 05/13/2003 | US6562792 Hygromycin derivatives |
| 05/13/2003 | CA2202992C Heterocycle substituted propenoic acid derivatives as nmda antagonists |
| 05/08/2003 | WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 05/08/2003 | US20030087882 Antiinflammatory agents |
| 05/08/2003 | CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 05/07/2003 | EP1307445A1 Benzofuran derivatives and their use as antibacterial agents |
| 05/07/2003 | EP0889863B1 Surface modified carbonate materials |
| 05/07/2003 | CN1416428A Compounds having antitumor activity: process for their prepn.and pharmaceutical compsns. contg. them |
| 05/06/2003 | US6559137 Characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient |
| 05/06/2003 | US6558942 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| 05/02/2003 | EP1306371A1 Cyclic imines |
| 05/02/2003 | EP1037886B1 Triazine angiogenesis inhibitors |
| 05/02/2003 | EP0901482B1 Benzofuran carboxamides and their therapeutic use |
| 05/01/2003 | WO2003035057A1 Inhibitors of dipeptidyl peptidase iv |
| 05/01/2003 | WO2003011873A3 Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
| 05/01/2003 | WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists |
| 05/01/2003 | US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/01/2003 | US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment |
| 05/01/2003 | US20030080323 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 04/30/2003 | CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 04/29/2003 | US6555561 Diaminopyridine-containing thiourea inhibitors of herpes viruses |
| 04/29/2003 | US6555559 5,6,7-trinor-4,8-inter-m-phenylene PGI2, derivative and drugs containing the same |
| 04/29/2003 | US6555028 Polymeric matrix compatibilized naphthopyrans |
| 04/24/2003 | WO2003033491A1 Medicinal composition for prevention or alleviation of side effect of antitumor and medicinal antitumor composition |
| 04/24/2003 | WO2003032979A1 Malignant cell differentiation inducer compositions and utilization of the same |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078260 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 04/24/2003 | US20030078258 Adrenergic blocking agents |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030077760 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| 04/24/2003 | US20030077707 Adjusting transferase domain in modular polyketide synthase; obtain nucleotide sequences, adjust sequences, express sequences, monitor activity of synthase |
| 04/23/2003 | EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/23/2003 | EP1303520A1 Therapeutic compounds and methods |
| 04/23/2003 | EP1303509A1 Beta3 adrenergic agonists |
| 04/23/2003 | EP0885391B1 Method of detection of influenza virus and compounds for use therein |
| 04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
| 04/23/2003 | CN1106381C Preparation process of nitroguanidine derivatives |
| 04/22/2003 | US6552205 C10 OXO and hydrido taxane derivatives and pharmaceutical compositions containing them |
| 04/22/2003 | US6552073 Compounds and methods of treating cell proliferative diseases |
| 04/22/2003 | US6552017 Substituted heterocycle fused gamma-carbolines |
| 04/22/2003 | CA2239187C Inhibitors of farnesyl protein transferase |
| 04/17/2003 | WO2003031449A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 04/17/2003 | US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents |
| 04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
| 04/16/2003 | CN1411457A Substituted pyrroles |
| 04/16/2003 | CN1410422A Benzfuran compound |
| 04/15/2003 | US6548546 HIV integrase inhibitors |
| 04/15/2003 | US6548536 Tetrocarcin derivative; treating cancer, AIDS, AIDS related condition (ARC), osteoarthritis, autoimmune diseases, collagenosis, and arteriosclerosis |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/10/2003 | WO2003029238A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | WO2003029215A1 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | WO2003028662A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 04/10/2003 | US20030069224 Non-nucleoside reverse transcriptase inhibitors |
| 04/10/2003 | US20030069204 Strain of streptomyces |
| 04/10/2003 | US20030069192 May be administered along with Rutin, a Rutin congener and/or a Rutin derivative. |
| 04/10/2003 | US20030069140 Herbicides |
| 04/10/2003 | US20030068677 Recombinant production of novel polyketides |
| 04/10/2003 | US20030066988 Electroconductivity coloring |
| 04/10/2003 | CA2462661A1 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 04/10/2003 | CA2461381A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | CA2460168A1 4¬piperidin-4-yliden-(3-carbamoylphenyl)methyl| benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/09/2003 | EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 04/09/2003 | EP1001766B1 Compounds for the treatment of ccr5-mediated diseases |
| 04/09/2003 | EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/09/2003 | EP0758327B1 Pyranone compounds useful to treat retroviral infections |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/03/2003 | WO2003027104A1 Fumagillol derivatives and preparing method thereof |
| 04/03/2003 | WO2002074738A3 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 04/03/2003 | US20030065200 Taxanes having T-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065007 Analgesics; psychological disorders; antidepressants |
| 04/03/2003 | US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/03/2003 | US20030064985 Prevent virus reproduction |
| 04/03/2003 | US20030064982 Pyrazole compounds useful as protein kinase inhibitors |
| 04/03/2003 | US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 04/02/2003 | EP0681574B1 C7 Taxane derivatives and pharmaceutical compositions containing them |
| 04/02/2003 | CN1407978A Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 04/02/2003 | CN1406937A 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/27/2003 | WO2003024975A1 Laulimalide-derivatives, their use and process for the production of laulimalide and laulimalide-derivatives |
| 03/27/2003 | WO2003024952A1 Bioprecursors for percutaneous application |
| 03/27/2003 | WO2003024950A1 Coumarin derivative |
| 03/27/2003 | WO2003024949A1 Dna-pk inhibitors |
| 03/27/2003 | WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 03/27/2003 | US20030060638 C7 carbamate substituted taxanes |
| 03/27/2003 | US20030060473 Piperazine compounds as inhibitors of MMP or TNF |
| 03/27/2003 | CA2460783A1 Bioprecursors for percutaneous application |
| 03/27/2003 | CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases |
| 03/26/2003 | EP1295886A1 Laulimalide-derivates, their use and process for the production of laulimalide and laulimalide-derivates |
| 03/26/2003 | EP1295881A1 Compositions for treating or preventing malaria and method of treating malaria |
| 03/26/2003 | EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 03/26/2003 | EP1098893B1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 03/26/2003 | EP1075263B1 Aqueous process for manufacturing paroxetine solid dispersions |
| 03/26/2003 | EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation |
| 03/26/2003 | EP0973756B1 Thiodepsipeptides for combating endoparasites and a method for producing the same |
| 03/26/2003 | CN1405162A C7 ester-substituted taxane |